IHC Kits and Reagents Citations

OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.

Search citations by gene symbols or target names

Here are some of the recent papers making use of OriGene products by fellow researchers.

Target Research Paper Journal Product SKU
The Binding of PD-L1 and Akt Facilitates Glioma Cell Invasion Upon Starvation via Akt/Autophagy/F-Actin Signaling Front Oncol., 2019 Dec IHC Kits and Reagents D13-6
A 3D epithelial–mesenchymal co-culture model of human bronchial tissue recapitulates multiple features of airway tissue remodeling by TGF-ß1 treatment Respir Res, 2019 Nov IHC Kits and Reagents D39-6
Triple Therapy with MerTK and PD1 Inhibition plus Radiotherapy Promotes Abscopal Antitumor Immune Responses Clin Cancer Res, 2019 Sep IHC Kits and Reagents D39-6
CARMA3/NF-?B signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate World J Gastroenterol., 2019 Sep IHC Kits and Reagents D39-6
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes EBioMedicine, 2019 Jul IHC Kits and Reagents D39-6
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes EBioMedicine, 2019 Jul IHC Kits and Reagents D37-6
Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma EBioMedicine., 2019 Jul IHC Kits and Reagents D41-6
Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma EBioMedicine., 2019 Jul IHC Kits and Reagents D39-6
Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma EBioMedicine., 2019 Jul IHC Kits and Reagents D37-6
Interleukin (IL)-13 and IL-17A contribute to neo-osteogenesis in chronic rhinosinusitis by inducing RUNX2 EBioMedicine, 2019 Jul IHC Kits and Reagents D41-6
Interleukin (IL)-13 and IL-17A contribute to neo-osteogenesis in chronic rhinosinusitis by inducing RUNX2 EBioMedicine, 2019 Jul IHC Kits and Reagents D39-6
Interleukin (IL)-13 and IL-17A contribute to neo-osteogenesis in chronic rhinosinusitis by inducing RUNX2 EBioMedicine, 2019 Jul IHC Kits and Reagents D37-6
Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients Cells, 2019 Jun IHC Kits and Reagents DS204A-6
LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p Cancer Med., 2019 Jun IHC Kits and Reagents D13-6
Revisiting the Clinical Scoring System for the Prognosis of Chronic Rhinosinusitis with Nasal Polyps Yonsei Med J., 2019 May IHC Kits and Reagents D41-6
Revisiting the Clinical Scoring System for the Prognosis of Chronic Rhinosinusitis with Nasal Polyps Yonsei Med J., 2019 May IHC Kits and Reagents D39-6
Revisiting the Clinical Scoring System for the Prognosis of Chronic Rhinosinusitis with Nasal Polyps Yonsei Med J., 2019 May IHC Kits and Reagents D37-6
Integration of metabolomics and expression of enolase-phosphatase 1 links to hepatocellular carcinoma progression Theranostics, 2019 May IHC Kits and Reagents D11-6
Integration of metabolomics and expression of enolase-phosphatase 1 links to hepatocellular carcinoma progression Theranostics, 2019 May IHC Kits and Reagents D12-6
Integration of metabolomics and expression of enolase-phosphatase 1 links to hepatocellular carcinoma progression Theranostics, 2019 May IHC Kits and Reagents D13-6
Inhibition of Brd4 alleviates renal ischemia/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress Redox Biol, 2019 Apr IHC Kits and Reagents D11-6
Inhibition of Brd4 alleviates renal ischemia/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress Redox Biol, 2019 Apr IHC Kits and Reagents D12-6
Inhibition of Brd4 alleviates renal ischemia/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress Redox Biol, 2019 Apr IHC Kits and Reagents D13-6
Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients Cancer Cell Int., 2019 Apr IHC Kits and Reagents D43-6
LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer Invest New Drugs, 2019 Feb IHC Kits and Reagents D11-6
LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer Invest New Drugs, 2019 Feb IHC Kits and Reagents D12-6
LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer Invest New Drugs, 2019 Feb IHC Kits and Reagents D13-6
Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice Front Immunol., 2019 Jan IHC Kits and Reagents D46-6
Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice Front Immunol., 2019 Jan IHC Kits and Reagents D39-6
Detection of circulating tumor cells in patients with pituitary tumors BMC Cancer. IHC Kits and Reagents D41-6
Detection of circulating tumor cells in patients with pituitary tumors BMC Cancer. IHC Kits and Reagents D39-6
Detection of circulating tumor cells in patients with pituitary tumors BMC Cancer. IHC Kits and Reagents D37-6
BCAT1 promotes proliferation of endometrial cancer cells through reprogrammed BCAA metabolism Int J Clin Exp Pathol., 2018 Dec IHC Kits and Reagents D39-6
Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma Medicine (Baltimore), 2018 Aug IHC Kits and Reagents D11-6
Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma Medicine (Baltimore), 2018 Aug IHC Kits and Reagents D12-6
Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma Medicine (Baltimore), 2018 Aug IHC Kits and Reagents D13-6
H3K4me3 and Wdr82 are associated with tumor progression and a favorable prognosis in human colorectal cancer Oncol Lett, 2018 Jun IHC Kits and Reagents D13-6
Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer BMC Cancer, 2018 May IHC Kits and Reagents D37-6
Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer BMC Cancer, 2018 May IHC Kits and Reagents D39-6
Cell-centred meta-analysis reveals baseline predictors of anti-TNFa non-response in biopsy and blood of patients with IBD Gut, 2018 Apr IHC Kits and Reagents D11-6
Cell-centred meta-analysis reveals baseline predictors of anti-TNFa non-response in biopsy and blood of patients with IBD Gut, 2018 Apr IHC Kits and Reagents D12-6
Cell-centred meta-analysis reveals baseline predictors of anti-TNFa non-response in biopsy and blood of patients with IBD Gut, 2018 Apr IHC Kits and Reagents D13-6
High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma , 2018 Mar IHC Kits and Reagents D41-6
High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma , 2018 Mar IHC Kits and Reagents D39-6
High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma , 2018 Mar IHC Kits and Reagents D37-6
Effects of splanchnic vasoconstrictors on liver regeneration and survival after 90% rat hepatectomy Ann Surg Treat Res, 2018 Feb IHC Kits and Reagents D39-6
Interleukin-10 promotes primary rat hepatic stellate cell senescence by upregulating the expression levels of p53 and p21 Mol Med Rep., 2018 Feb IHC Kits and Reagents D41-6
Interleukin-10 promotes primary rat hepatic stellate cell senescence by upregulating the expression levels of p53 and p21 Mol Med Rep., 2018 Feb IHC Kits and Reagents D39-6
Interleukin-10 promotes primary rat hepatic stellate cell senescence by upregulating the expression levels of p53 and p21 Mol Med Rep., 2018 Feb IHC Kits and Reagents D37-6
Interleukin-10 promotes primary rat hepatic stellate cell senescence by upregulating the expression levels of p53 and p21 Mol Med Rep., 2018 Feb IHC Kits and Reagents D46-6